Education
About Us
Working with TipRanks
Follow Us
Blue Jet Healthcare Limited (IN:BLUEJET)
:BLUEJET
BLUEJET Stock Chart & Stats
₹653.45
-₹16.80(-2.80%)
At close: 4:00 PM EST
₹653.45
-₹16.80(-2.80%)
Day’s Range― - ―
52-Week Range₹352.75 - ₹1,028.20
Previous CloseN/A
Volume75.53K
Average Volume (3M)19.19K
Market Cap
₹71.02B
Enterprise Value₹69.21B
Total Cash (Recent Filing)₹3.06B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)23.1
Beta1.07
Next Earnings
May 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.22%
Share Statistics
EPS (TTM)2.30
Shares Outstanding173,465,420
10 Day Avg. Volume15,409
30 Day Avg. Volume19,187
Financial Highlights & Ratios
PEG Ratio0.55
Price to Book (P/B)12.87
Price to Sales (P/S)14.16
P/FCF Ratio-427.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA 45% revenue jump to ₹10,299M in 2025 demonstrates durable demand and successful market penetration in API markets. Sustained top-line growth supports scale economics, reinvestment in capacity and specialty molecules, and long-term revenue visibility from B2B contracts.
Profitability & MarginsElevated gross and net margins plus strong EBIT/EBITDA margins point to a high-margin product mix and efficient manufacturing. Persistent margin strength enhances resilience to input cost swings and supports sustainable internal funding for R&D and quality/compliance investments.
Strong Balance SheetExtremely low leverage and a high equity ratio provide financial flexibility to fund capex, absorb shocks, and pursue growth without heavy external financing. High ROE shows effective capital deployment, supporting durable shareholder returns potential over time.
Bears Say
Negative Free Cash FlowA swing to negative FCF is a material structural concern: it constrains the company’s ability to self-fund capex, working capital and strategic projects. Persistent negative FCF could force external financing or slow investments despite strong accounting profits.
Weak Cash ConversionA 0.15 operating cash flow to net income ratio shows earnings are not translating into cash efficiently. This can reflect higher receivables, inventory or payment-term pressure; if durable, it undermines liquidity and makes earnings less reliable for funding needs.
Customer Disclosure / Concentration RiskLack of disclosed major-customer or segment detail masks potential customer concentration. In a B2B contract manufacturing model, reliance on a few large pharma clients can create outsized revenue risk if contracts are lost or volumes shift, increasing business volatility.
Blue Jet Healthcare Limited News
BLUEJET FAQ
What was Blue Jet Healthcare Limited’s price range in the past 12 months?
Blue Jet Healthcare Limited lowest stock price was ₹352.75 and its highest was ₹1028.20 in the past 12 months.
What is Blue Jet Healthcare Limited’s market cap?
Blue Jet Healthcare Limited’s market cap is ₹71.02B.
When is Blue Jet Healthcare Limited’s upcoming earnings report date?
Blue Jet Healthcare Limited’s upcoming earnings report date is May 25, 2026 which is in 88 days.
How were Blue Jet Healthcare Limited’s earnings last quarter?
Blue Jet Healthcare Limited released its earnings results on Feb 13, 2026. The company reported ₹2.3 earnings per share for the quarter, missing the consensus estimate of ₹3.55 by -₹1.25.
Is Blue Jet Healthcare Limited overvalued?
According to Wall Street analysts Blue Jet Healthcare Limited’s price is currently Overvalued.
Does Blue Jet Healthcare Limited pay dividends?
Blue Jet Healthcare Limited pays a Notavailable dividend of ₹1.2 which represents an annual dividend yield of 0.22%. See more information on Blue Jet Healthcare Limited dividends here
What is Blue Jet Healthcare Limited’s EPS estimate?
Blue Jet Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blue Jet Healthcare Limited have?
Blue Jet Healthcare Limited has 173,465,420 shares outstanding.
What happened to Blue Jet Healthcare Limited’s price movement after its last earnings report?
Blue Jet Healthcare Limited reported an EPS of ₹2.3 in its last earnings report, missing expectations of ₹3.55. Following the earnings report the stock price went down -9.998%.
Which hedge fund is a major shareholder of Blue Jet Healthcare Limited?
Currently, no hedge funds are holding shares in IN:BLUEJET
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blue Jet Healthcare Limited
Blue Jet Healthcare Limited (BLUEJET) is a dynamic player in the healthcare sector, focusing on the development and distribution of innovative medical products and services. The company operates primarily in the pharmaceuticals and medical devices sectors, offering a wide range of healthcare solutions designed to enhance patient care and operational efficiency in healthcare facilities. Core products include advanced medical devices, diagnostic tools, and a portfolio of pharmaceutical products aimed at addressing various health conditions.
Technical Analysis
Biocon Limited
―
Concord Biotech Ltd.
―
Jubilant Ingrevia Ltd.
―
Supriya Lifescience Limited
―
Syngene International Ltd.
―